Developed in collaboration with 9amHealth, the new offering gives employers flexible strategies to deliver and manage specialty cardiometabolic care across their organizations
TEMPE, Ariz., Sept. 23, 2026 /PRNewswire-PRWeb/ -- Personify Health®, the company making healthier easier and less costly, today unveiled Transform+, a comprehensive weight management and cardiometabolic care solution designed to help employers address the growing clinical and financial challenges associated with GLP-1s. Transform+ was developed in collaboration with 9amHealth, a specialty care platform, and expands Personify Health's ability to provide members with access to specialized clinical care, personalized treatment plans, and evidence-based medication and lifestyle management. It will be available starting January 1, 2027, as part of the Personify Health Transform Solution Suite.
GLP-1s have quickly become one of the fastest-growing cost drivers for employer health plans, forcing them to make high-stakes benefit decisions that require a strategy beyond prescription access alone. Total GLP-1 spending increased more than 500% between 2018 and 2023, with branded therapies costing employers more than $12,000 per member annually. The number of Americans using GLP-1 therapies is projected to rise from 10 million in 2025 to 25 million by 2030, and broad GLP-1 coverage could increase employer health plan premiums by 5.3% to 13.8%. Reflecting this trend, employer healthcare costs are projected to increase 9.5% in 2027, with GLP-1 adoption as a key factor driving higher pharmacy spending.
Transform+ gives employers a more connected way to manage these challenges. By combining Personify Health's industry-leading engagement and navigation capabilities with 9amHealth's specialist-developed cardiometabolic care model, the solution helps members receive the right level of clinical oversight, medication management, and behavior-change support based on their individual needs.
The new Transform+ is designed to support employers across different GLP-1 coverage strategies, whether they are committed to providing broad access or looking for a more controlled way to manage rising spend:
- For employers committed to full coverage, Transform+ establishes a step therapy framework that helps ensure GLP-1 access for cardiometabolic disease and weight management that is clinically appropriate and evidence-based from the first prescription.
- For employers wrestling with the trajectory of GLP-1 spend, Transform+ offers a tele-prescribing model paired with a controlled medication stipend, giving benefits leaders a structured path to manage cost exposure without abandoning member access to therapy.
"Not everyone needs a GLP-1, but everyone deserves a clear path to better metabolic health," said Jeffrey Jacques, MD, chief medical officer at Personify Health. "By combining the individual strengths and capabilities of Personify Health and 9amHealth, Transform+ gives employers a smarter and more personalized way to match each member to the right level of support, from lifestyle-first programs to comprehensive clinical care, while helping manage the costs associated with rapidly growing demand for GLP-1 medications and other treatments."
Personify Health's market-leading engagement platform directs the member through an obesity management care journey to contain and avoid unnecessary costs. Lower-acuity members are connected to Transform's digital lifestyle and behavior-change programs, while those with more complex cardiometabolic needs are navigated to Transform+, powered by 9amHealth. For members navigated to Transform+, the program takes a whole-person approach that supports GLP-1 coverage through a more controlled, clinically guided care path, including specialty care, prescribing oversight, fitness and nutrition guidance, and utilization management when appropriate.
"9amHealth has built a proven clinical care model that delivers better outcomes, a more personalized member experience, and lower costs at scale," said Avantika Waring, MD, chief medical officer at 9amHealth. "Together with Personify Health, we can bring that care to more people, giving organizations a clinically responsible way to manage GLP-1 access and provide specialty cardiometabolic care for people with more complex needs."
The potential impact of the combined offering is underscored by results from 9amHealth's cardiometabolic care program, which demonstrates meaningful clinical and cost improvements. Employers using 9amHealth have experienced at least 2.6x ROI in year one, and two Fortune 100 companies are moving toward $55M in projected medical and pharmacy savings. Members have seen outcomes including an average 17.6% weight reduction with a GLP-1 medication, and 9.3% with lower-cost medications; up to 2.8% A1c reduction in individuals with unmanaged diabetes; and blood pressure reductions averaging 19.8/12.9 mmHg.
The Transform Solution Suite is Personify Health's collection of digital disease management programs designed to help prevent and manage chronic conditions, including prediabetes, weight management, and blood pressure. It combines behavior-tracking tools, connected devices, evidence-based curriculum, and personalized health coaching to support lasting lifestyle changes. By helping members reduce their risk of developing serious illnesses, Transform delivers proven clinical outcomes while lowering healthcare costs for clients, including a 58% reduction in the risk of developing Type 2 Diabetes among participants who achieve program goals, and improved eating habits for 64% of participants.
Join a live webinar on October 7, 2026, at 1:00 p.m. ET to learn how leading organizations are approaching cardiometabolic health beyond medication access alone. During this session, Dr. Jeffrey Jacques and Dr. Avantika Waring will explore the drivers of rising healthcare costs, common gaps employers experience when supporting GLP-1 users, and how to align better health outcomes with more sustainable healthcare spending. Register on our website.
About Personify Health
Personify Health is on a mission to make health simple, personal, and engaging. We created the industry's first and only personalized health platform, seamlessly fusing smart third party administration (TPA), digital care navigation, and health engagement into one dynamic, connected experience. Our platform addresses the full health continuum, harnessing cutting-edge AI and human expertise to provide a comprehensive set of solutions, ecosystem partnerships, and integrated services that deliver real, independently validated clinical outcomes and cost savings. Empowering 25 million members and having supported 7,500 companies to date, we are redefining how businesses and people experience health. Visit www.personifyhealth.com to learn how healthier lives and healthier businesses happen with Personify Health.
All trademarks, service marks, and logos displayed on these materials (the "Trademark(s)") are registered and unregistered trademarks of Personify Health, Inc. or third parties who have licensed their Trademarks to Personify Health, Inc. All other trademarks, registered or unregistered, are the property of their respective owners.
Media Contact
Kara Spak, Personify Health, 1 475-399-4055, [email protected], https://personifyhealth.com/
SOURCE Personify Health
Share this article